Aktuellt
SENASTE
Redeye leaves its initial comments on Heliospectras’ Q4 2023 report, in which the figures were slightly softer than expected. However, OPEX was well below our forecast, indicating that the cost reduction program continues to yield results. We will probably revise our short-term forecasts downward on the back of the slower-than-expected order intake in the quarter.
LÄS MER
